Cinematherapy for Women With Depression and Anxiety (GINEMOTION)

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Completed

Conditions

Depression Anxiety Disorder

Treatments

Behavioral: Cinematherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06884033

7075

Details and patient eligibility

About

Group cinematherapy program in reducing depressive and anxiety symptoms in women diagnosed with Depressive Disorders and Anxiety Disorders.

Full description

Cinematherapy is a creative therapeutic intervention in which a trained professional prescribes the patient to watch a film and uses the characters and themes as metaphors to promote self-exploration and change. The effectiveness of cinematherapy as a therapeutic technique has been demonstrated through its effectiveness in improving participants' self-esteem, emotional expression and understanding, and interpersonal relationships, and in reducing depressive and anxious symptoms.The cinematherapy intervention involves a targeted selection of film content and activities designed to improve the patients' mental condition.The study includes eight meetings on a monthly basis (programming of eight films lasting approximately two hours and subsequent discussion on the contents of the film shown).

Enrollment

30 patients

Sex

Female

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

female, aged 18-75 years;
Diagnosis of Depressive Disorders (unipolar and bipolar) and Anxiety Disorders according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5), both new onset in subjects without a previous psychiatric history, and depressive and anxious recurrences;
Taking psychopharmacological therapy;
Fluent knowledge of the Italian language;
Release of a written informed consent, signed by the patient or legal representative and partner.

Exclusion criteria

Diagnosis of Schizophrenia or other psychotic spectrum disorders;
Diagnosis of neurological disorders associated with cognitive decline;
Current abuse of alcohol and psychotropic substances, with the exception of smoking;
Refusal to sign the informed consent to participate in the study.